PrEP medications can help make an impact on the HIV epidemic
Oral PrEP usage was associated with a reduction in new HIV diagnoses1
Estimated annual percentage change in HIV diagnoses rates by state quintile of PrEP usage, 2012 to 2021, United States*
In a real-world retrospective analysis, states in the high-use quintile for PrEP had the greatest reduction in HIV diagnoses from 2012 to 2021, after accounting for state viral suppression.1†
*The publicly available data on PrEP prescriptions and CDC estimates of people with PrEP indications were used to determine mean PrEP coverage (calculated as number of PrEP users/100 persons with indications) from 2012 to 2021 by quintiles for 50 US states and the District of Columbia. For each PrEP quintile, EAPC in HIV diagnosis rates from 2012 to 2021 was calculated with a CI of 95% using temporal trends models and a p value for trend across state-specific quintiles of coverage. EAPC estimates were adjusted for prior state-level viral suppression to account for higher PrEP coverage in states confounded by higher levels of viral suppression.1
†Data shown for quintiles are trends and do not represent EAPC for each individual state.
Decrease in HIV acquisition linked to timely initiation of PrEP
According to a real-world study analyzing PrEP prescriptions between 2019 and 20232‡:
- Timely initiation of PrEP was linked to a decrease in HIV acquisition
- Any delay in initiating PrEP§ was associated with a higher chance of acquiring HIV
Help individuals promptly start PrEP, and encourage discussion about HIV prevention
(Tao, 2023)
‡522,273 prescriptions of PrEP for CAB, F/TDF, or F/TAF were analyzed between January 2019 and February 2023, selected from IQVIA® LAAD.2
§Study compared delays of PrEP dispensation from day 0, when PrEP was dispensed.2
View your local PrEP data
See estimates of how many people in your area are prescribed PrEP vs how many are currently indicated for it.
County-level data are available for some territories, but not all. Where county-level data are unavailable, state-level data are shown.
Search by county or state:
¶State and county numbers have been rounded down to the nearest 100.
**State and county PrEP prescriptions include FTC/TDF, DESCOVY FOR PrEP®, and CAB-LA.3
CAB=cabotegravir; CAB-LA=long-acting cabotegravir; CDC=Centers for Disease Control and Prevention; CI=confidence interval; EAPC=estimated annual percentage change; F/TAF=tenofovir alafenamide; F/TDF=tenofovir disoproxil fumarate; FTC/TDF=emtricitabine/tenofovir disoproxil fumarate; IQVIA LAAD=IMS Health, Quintiles, and VIA Longitudinal Access and Adjudication Data.
